PL362716A1 - Nowy sposób - Google Patents

Nowy sposób

Info

Publication number
PL362716A1
PL362716A1 PL01362716A PL36271601A PL362716A1 PL 362716 A1 PL362716 A1 PL 362716A1 PL 01362716 A PL01362716 A PL 01362716A PL 36271601 A PL36271601 A PL 36271601A PL 362716 A1 PL362716 A1 PL 362716A1
Authority
PL
Poland
Prior art keywords
new process
new
Prior art date
Application number
PL01362716A
Other languages
English (en)
Inventor
Ronald James Ogilvie
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of PL362716A1 publication Critical patent/PL362716A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL01362716A 2000-12-20 2001-12-06 Nowy sposób PL362716A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031094.6A GB0031094D0 (en) 2000-12-20 2000-12-20 New Process
PCT/IB2001/002338 WO2002050063A1 (en) 2000-12-20 2001-12-06 New process

Publications (1)

Publication Number Publication Date
PL362716A1 true PL362716A1 (pl) 2004-11-02

Family

ID=9905487

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01362716A PL362716A1 (pl) 2000-12-20 2001-12-06 Nowy sposób

Country Status (20)

Country Link
EP (1) EP1373254B1 (pl)
JP (1) JP2004516290A (pl)
KR (1) KR20030061448A (pl)
CN (1) CN1199969C (pl)
AR (2) AR035406A1 (pl)
AT (1) ATE308539T1 (pl)
AU (1) AU2002218440A1 (pl)
BR (1) BR0116324A (pl)
CA (1) CA2432138C (pl)
CZ (1) CZ20031640A3 (pl)
DE (1) DE60114668T2 (pl)
ES (1) ES2249386T3 (pl)
GB (1) GB0031094D0 (pl)
HU (1) HUP0302465A2 (pl)
IL (1) IL155706A0 (pl)
MX (1) MXPA03005569A (pl)
PL (1) PL362716A1 (pl)
RU (1) RU2256660C2 (pl)
WO (1) WO2002050063A1 (pl)
ZA (1) ZA200303446B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US6927296B2 (en) 2003-07-23 2005-08-09 Pfizer Inc. Process
EP2093225A1 (en) * 2007-05-01 2009-08-26 Plus Chemicals B.V. Process for preparing crystalline eletriptan hydrobromide form ß
IT1393700B1 (it) * 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011024039A1 (en) * 2009-08-25 2011-03-03 Ramesh Babu Potluri Synthesis of novel 5-(2-(phenylsulfonyl)ethyl)-1h-indole derivatives
WO2011089614A1 (en) 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2012004811A1 (en) * 2010-07-06 2012-01-12 Ind-Swift Laboratories Limited Process for the preparation of 5-substsituted indole derivative
WO2017125351A1 (en) 2016-01-21 2017-07-27 Laboratorios Lesvi Sl Process for preparing (( r)-3-[(-1-methylpyrrolidin-2-yl)methyl]-5-(2-phenylsulfonylethyl)-1h-indole
CN112440631B (zh) * 2020-11-02 2022-09-13 长城汽车股份有限公司 一种调节胎压装置、方法、系统以及车辆

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL168919B1 (pl) * 1990-10-15 1996-05-31 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
CN1487932A (zh) 2004-04-07
AR043016A2 (es) 2005-07-13
ES2249386T3 (es) 2006-04-01
CN1199969C (zh) 2005-05-04
EP1373254B1 (en) 2005-11-02
DE60114668T2 (de) 2006-07-20
JP2004516290A (ja) 2004-06-03
AU2002218440A1 (en) 2002-07-01
CA2432138A1 (en) 2002-06-27
DE60114668D1 (de) 2005-12-08
EP1373254A1 (en) 2004-01-02
ATE308539T1 (de) 2005-11-15
WO2002050063A1 (en) 2002-06-27
HUP0302465A2 (hu) 2003-12-29
AR035406A1 (es) 2004-05-26
RU2256660C2 (ru) 2005-07-20
ZA200303446B (en) 2004-07-05
GB0031094D0 (en) 2001-01-31
IL155706A0 (en) 2004-02-19
CZ20031640A3 (cs) 2004-08-18
BR0116324A (pt) 2003-10-14
CA2432138C (en) 2007-05-08
KR20030061448A (ko) 2003-07-18
MXPA03005569A (es) 2003-10-06

Similar Documents

Publication Publication Date Title
GB0011120D0 (en) Process
GB0025221D0 (en) New process
GB0020523D0 (en) Process
GB0023781D0 (en) Process
GB0013793D0 (en) Process
GB0010437D0 (en) Process
GB0020021D0 (en) Process
GB0002201D0 (en) Process
GB0031094D0 (en) New Process
GB0014583D0 (en) Process
GB0021488D0 (en) Process
GB0013791D0 (en) Process
GB0025310D0 (en) Process
GB0016633D0 (en) Process
GB0001564D0 (en) Process
GB0020738D0 (en) Process
GB0026490D0 (en) Process
GB0012448D0 (en) New process
GB0007517D0 (en) Process
GB0000936D0 (en) Process
GB0006837D0 (en) Process
GB0007005D0 (en) Process
GB0000934D0 (en) Process
GB0009709D0 (en) Process
GB0011069D0 (en) Process

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)